Webinar: Palmar Foot Pain | Advances and Updates in Equine Podiatry
ArthramidVet hosted this discussion with Dr Andrew Watts and Dr Tracy Turner, experts in equine foot health. Our Panelists Dr Andrew Watts (AU): Graduating from University of Queensland in…
Contura Animal Health Holdings acquires Innovative Medical Solutions
Contura Vet Limited, a wholly owned subsidiary of Contura Animal Health Holdings Limited, (“Contura Vet”), the owner and distributor of ArthramidVet®, an innovative veterinary medical product used for the treatment…
Successful Treatment of a chronic tendon sheath injury with ArthramidVet® 2.5 iPAAG.
A Star Performer: 12-Year-Old Showjumping Crossbred Gelding In this case report we look at a 12-year-old crossbred gelding who show jumps competitively to 1.40m. Recently, the gelding developed acute tenosynovitis…
Case Report on a 9-year-old Warmblood mare, seasoned in Prix St. George dressage
Despite her talents the 9-year-old warmblood mare had difficulty in collecting behind, diminished power, and a reluctance to perform her best. No asymmetry was detected, so to uncover the root…
Dr Lisa Fortier Seminar | Intra-Articular Approaches to Osteoarthritis
ArthramidVet® and the NZVA offered an exclusive opportunity to hear from the esteemed Dr Lisa Fortier who, alongside Dr Jason Lowe, discussed Intra-Articular Approaches to Osteoarthritis, a general topic that…
ArthramidVet: getting Oscar back in the arena
Oscar, a KPWN Dutch Warmblood was bred and started in Europe, where he was internationally trained and competed up to Small Tour in UK and Netherlands. Oscar arrived in Australia…
Histologic and cytologic changes in normal equine joints after injection with 2.5% iPAAG hydrogel reveal low-level macrophage-driven foreign body response
The prestigious American Veterinary Medicine Association has published another 2.5% iPAAG (ArthramidVet®) study conducted by IMS Vet Directors Dr Jason Lowe and Dr Leigh de Clifford, in keeping with our…
New and Upcoming Advances in Equine Orthopedics
Updates on 2.5% iPAAG (Polyacrylamide Hydrogel) In our latest webinar, a number of expert practitioners discussed the latest findings of the use of 2.5% iPAAG (ArthramidVet) and upcoming advances. EquiManagement…
Recommendations and Safety of repeat dosing with 2.5% iPAAG ArthramidVet®
Introduction ArthramidVet® is a novel treatment and represents a paradigm shift in how veterinarians and owners think about treating lameness in horses. ArthramidVet® can be used in any joint that…
Rolo’s Road to Comfort: Inspiring Equine and Human Well-Being
Horses often show discomfort in a number of ways and it doesn’t always result in visual lameness or apparent discomfort. This was the case for Rolo, whose diagnosis wasn’t particularly…
2023 North American Veterinary Regenerative Medicine Conference
Outrigger Kona Resort and Spa in Kona, Hawai’i September 22 – 24. Dr Jason Lowe presented his paper in a brief 15-minute talk. Histologic and cytologic changes in normal equine…
Testimonial | Simon Zahra
Simon Zahra is a familiar face in the thoroughbred racing game, he grew up in the industry, he’s been training for about 25 years and was also a part of…
